SCHEMBL7446642

SCHEMBL7446642

C=CCC(C(=O)OC)C(CC(=O)O)c1cccc(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.39
CYP2C19 P33261 2/20 0.39
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
ALOX15 P16050 1/20 0.38
CYP26A1 O43174 1/20 0.38
CNR2 P34972 1/20 0.38
HDAC4 P56524 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
FFAR1 O14842 2/20 0.37
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
CTSA P10619 2/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7447268 0.89 KDM4E (0.40) KDM4ECYP2C19POLBMAPTMAPK1
SCHEMBL4022595 0.73 CYP2C19 (0.68) CYP2C19CNR2HDAC4HDAC7HDAC5
SCHEMBL27338142 0.73 FFAR1 (0.45) CYP2C19POLBMAPTMAPK1CYP2D6
SCHEMBL20826236 0.72 HDAC4 (0.44) KDM4ECYP2C19POLBMAPTMAPK1
SCHEMBL27433662 0.71 CYP2C19 (0.47) CYP2C19MAPTMAPK1CYP2D6ALDH1A1
SCHEMBL25242939 0.70 HDAC4 (0.47) KDM4ECYP2C19POLBMAPTMAPK1
SCHEMBL31038318 0.70 HDAC4 (0.47) KDM4ECYP2C19POLBMAPTMAPK1
SCHEMBL7216851 0.70 HDAC4 (0.44) CYP26A1CNR2HDAC4HDAC7HDAC5
SCHEMBL9114061 0.70 CYP2C19 (0.67) CYP2C19ALDH1A1LMNAKMT2AMEN1
SCHEMBL29449418 0.70 HDAC4 (0.50) KDM4ECYP2C19POLBMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1105389-A4 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2001-10-17 EP disclosed
EP-1105389-A1 INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2001-06-13 EP disclosed
US-6090944-A Alkanoic acid derivatives as αv integrin receptor antagonists MERCK & CO., INC. (US) 2000-07-18 US disclosed
WO-2000009503-A1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2000-02-24 WO disclosed